EUVIMEDEUVIMED entdecken
Crossref

Antimicrobial effect of pimozide by targeting ROS‐mediated killing in Staphylococcus aureus

Siddhartha Kumar, Kumar Sandeep, Rakesh Kumar, Antresh Kumar iD

Biotechnology and Applied Biochemistry · 2023

DOI: 10.1002/bab.2465 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biotechnology and Applied Biochemistry, 2023. Verfasst von Siddhartha Kumar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Central University of South Bihar, Gaya, Bihar, India. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Staphylococcal Infections, Anti-Infective Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In spite of the higher nosocomial and community‐acquired infections caused by Staphylococcus aureus , emerging drug resistance is a leading cause of increased mortality and morbidity associated with the overuse of antimicrobials. It is an emergent need to find out new molecules to combat such infections. In the present study, we analyzed the antibacterial effect of pimozide (PMZ) against gram‐positive and gram‐negative bacterial strains, including methicillin‐sensitive (MSSA) and methicillin‐resistant (MRSA) S. aureus . The growth of MSSA and MRSA was completely inhibited at concentrations of 12.5 and 100 μg/mL, respectively, which is referred to as 1× minimum inhibitory concentration (MIC). The cell viability was completely eliminated within 90 min of PMZ treatment (2× MIC) through reactive oxygen species (ROS)‐mediated killing without affecting cell membrane permeability. It suppressed α‐hemolysin production and biofilm formation of different S. aureus strains by almost 50% at 1× MIC concentration, and was found to detach matured biofilm. PMZ treatment effectively eliminates S. aureus infection in Caenorhabditis elegans and improves its survival by 90% and is found safe to use with no hemolytic effect on human and chicken blood tissues. Taken together, it is concluded that PMZ may turn out to be an effective antibacterial for treating bacterial infections including MSSA and MRSA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Methicillin-Resistant Staphylococcus aureusStaphylococcal InfectionsAnti-Infective AgentsHumansStaphylococcus aureusPimozideReactive Oxygen SpeciesAnti-Bacterial AgentsMethicillinMicrobial Sensitivity Tests

Stichwörter der Autor:innen

Caenorhabditis elegansROSStaphylococcus aureusantibacterial activitybiofilm inhibitiondrug repurposingpimozide

Substanzen

PimozideReactive Oxygen SpeciesAnti-Bacterial AgentsMethicillinAnti-Infective Agents

Autor:innen und Institutionen

  • Department of Biotechnology, Central University of South Bihar, Gaya, Bihar, India.
  • Dr. B.R. Ambedkar Institute - Rotary Cancer Hospital, AIIMS, New Delhi, India.
  • Department of Biochemistry, Central University of Haryana, Mahendergarh, Haryana, India.

ORCID-Profile: Antresh Kumar

Zitieren

APA

Kumar, S., Sandeep, K., Kumar, R., & Kumar, A. (2023). Antimicrobial effect of pimozide by targeting ROS‐mediated killing in Staphylococcus aureus. Biotechnology and Applied Biochemistry. https://doi.org/10.1002/bab.2465

Vancouver

Kumar S, Sandeep K, Kumar R, Kumar A. Antimicrobial effect of pimozide by targeting ROS‐mediated killing in Staphylococcus aureus. Biotechnology and Applied Biochemistry. 2023. doi:10.1002/bab.2465

BibTeX
@article{Kumar2023,
  author = {Kumar, Siddhartha and Sandeep, Kumar and Kumar, Rakesh and Kumar, Antresh},
  title = {Antimicrobial effect of pimozide by targeting ROS‐mediated killing in Staphylococcus aureus},
  journal = {Biotechnology and Applied Biochemistry},
  year = {2023},
  doi = {10.1002/bab.2465}
}
Kostenlos starten →